Moventig

Medicinal product

(Invented) name

Moventig

Active substance (s)

Naloksegolas

Strength

12,5 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A06AH03, Naloxegol

Marketing authorisation holder

Grünenthal GmbH, Vokietija

Date of authorisation

2014-12-08

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Naloksegolas	12,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
60895	75201	1075201	lizdinė plokštelė	N30		Receptinis	EU/1/14/962/001	Netiekiama	-	-	No	-	-
60896	75202	1075202	lizdinė plokštelė	N90		Receptinis	EU/1/14/962/002	Netiekiama	-	-	No	-	-
60897	75203	1075203	dalomoji lizdinė plokštelė	N90x1		Receptinis	EU/1/14/962/003	Netiekiama	-	-	No	-	-
98933	85037	1085037	dalomoji lizdinė plokštelė	N30x1		Receptinis	EU/1/14/962/008	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2014-12-08	Registruotas